From the Journals

Higher ADR continues to show ‘strong, consistent’ link with lower interval CRC


 

FROM JAMA

Factors to consider

The study is useful, but it doesn’t address the disparity in adenoma detection that exists between individual doctors, according to Dr. Kosinski, founder and chief medical officer of SonarMD and previously director of a large gastroenterology clinic. “Even if you look at doctors who do a minimum of 250 screening colonoscopies in a year, there’s still variability. There was even a study published in 2014 showing ADRs anywhere from 7.4% to 52.5%. The bell curve is broad,” he said.

As patients age, they have a higher frequency of polyps appearing on the right side of the colon, and those polyps are flatter and more easily missed than polyps on the left side. “The variation in ADR is higher on the right side of the colon than it is on the left. Doctors have to really do a very good job of examining that right side of the colon so that they don’t miss the flat polyps,” said Dr. Kosinski.

To improve ADRs, Dr. Kosinski emphasized the need to take the required time out to complete a procedure, despite the tight schedules often faced by ambulatory centers. “It’s the time you take coming out of the colon that’s critical. You owe it to the patient,” he said.

And if a patient hasn’t prepped well enough, it’s better to send the patient home without the procedure than to conduct a poor-quality screening. “If you can’t see the mucosal surface, you can’t tell the patient that they have a negative colonoscopy. If you have to do more cleaning during the procedure, then do more cleaning during the procedure. If you have to cancel the procedure and bring the patient back, it’s better to do that than it is to do an incomplete colonoscopy,” said Dr. Kosinski.

He also stressed the need to make sure that the patient is properly sedated and comfortable “so that you can do the job you’re supposed to do,” he said.

Some authors disclosed relationships with Amgen and the National Cancer Institute. Dr. Rex disclosed relationships with Olympus, Boston Scientific, Aries, and others, all outside the submitted work.

Pages

Recommended Reading

Fatty liver disease drives rise in liver cancer deaths
MDedge Hematology and Oncology
Fatty liver disease drives rise in liver cancer deaths
MDedge Hematology and Oncology
Impact of eliminating cost-sharing on follow-up colonoscopy mixed
MDedge Hematology and Oncology
CRC screening disparities greatest among those under 55
MDedge Hematology and Oncology
Medicare to cover colonoscopy after positive fecal test
MDedge Hematology and Oncology
High residual liver cancer risk in HCV-cured cirrhosis
MDedge Hematology and Oncology
New insights into worldwide biliary tract cancer incidence, mortality
MDedge Hematology and Oncology
U.S. hot, cold spots of young-onset CRC may help target interventions
MDedge Hematology and Oncology
Moderate drinking shows more benefit for older vs. younger adults
MDedge Hematology and Oncology
Barrett’s esophagus: AGA screening update ‘goes above and beyond’
MDedge Hematology and Oncology